{bc}

Tarsus Pharmaceuticals jobs and hiring trends

Pharmaceutical Manufacturing441 employeesFounded 2017

Company identity and hiring signals verified from public source listings

Active roles
29
New in 7 days
0
Hiring velocity
0.0 / wk
Top function
engineering
29 classified
Comparable salary
USD 150K–USD 210K / yearly
n=28
Remote-friendly
10%
3 of 29 classified

Observed daily snapshots

Active-role trend

Latest: 29 roles

Sep 8Oct 26

Observed active listings increased from 3 to 29 across 15 snapshot days. Missing days are left as gaps and are not estimated.

View accessible snapshot table
DateActive listings
2026-09-083
2026-09-093
2026-09-103
2026-09-113
2026-09-133
2026-09-2122
2026-09-3029
2026-10-0729
2026-10-1229
2026-10-1529
2026-10-1829
2026-10-1929
2026-10-2029
2026-10-2329
2026-10-2629

Listing recency

Source observation

Observed by source within 7 days
0 of 29
Latest source observation
Median posting age
—

Source observation shows when Base Career last saw listings at their source. It does not mean every listing was revalidated within the last 24 hours.

What this company is hiring for

Engineering10
Sales6
Healthcare4
Operations3
Data1
Hr1

Based on n=29 classified listings

Seniority mix

Senior21
Mid5
Entry3

Based on n=29 classified listings

Work model

Hybrid18
Field7
Remote3
Onsite1

Based on n=29 classified listings

Top hiring locations

Irvine, California, United States19
United States4
Ann Arbor, Michigan, United States1
Austin, Texas, United States1
Chicago, Illinois, United States1
Madison, Wisconsin, United States1

Based on n=29 classified listings

Comparable salary ranges

SeniorityMedian rangeSample
SeniorUSD 188K–USD 264K / yearlyn=21
MidUSD 110K–USD 161K / yearlyn=5

Verified active listings

Open roles at Tarsus Pharmaceuticals (29)

About Tarsus Pharmaceuticals

Public biopharmaceutical company developing and commercializing medicines for patients, initially focused on eye care.

Industry
Pharmaceutical Manufacturing
Company size
441 employees
Founded
2017
Facts checked
Sep 8, 2026